HERBERT H YU

Summary

Affiliation: Yale University
Country: USA

Publications

  1. pmc Global burden of cancer
    Xiaomei Ma
    Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut 06520 8034, USA
    Yale J Biol Med 79:85-94. 2006
  2. pmc TGF-beta1 genotype and phenotype in breast cancer and their associations with IGFs and patient survival
    L Mu
    Department of Epidemiology and Public Health, Yale Cancer Center, Yale University School of Medicine, New Haven, CT 06520 8034, USA
    Br J Cancer 99:1357-63. 2008
  3. pmc PDCD6 is an independent predictor of progression free survival in epithelial ovarian cancer
    Dan Su
    Center for Genetic and Genomic Medicine, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China
    J Transl Med 10:31. 2012
  4. ncbi request reprint Insulin-like growth factors and breast cancer risk in Chinese women
    Herbert Yu
    Department of Epidemiology and Public Health and Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut 06520 8034, USA
    Cancer Epidemiol Biomarkers Prev 11:705-12. 2002
  5. ncbi request reprint Plasma sex steroid hormones and breast cancer risk in Chinese women
    Herbert Yu
    Department of Epidemiology and Public Health and Yale Cancer Center, Yale University School of Medicine, New Haven, CT 06520 8034, USA
    Int J Cancer 105:92-7. 2003
  6. ncbi request reprint Joint effect of insulin-like growth factors and sex steroids on breast cancer risk
    Herbert Yu
    Yale University School of Medicine and Yale Cancer Center, New Haven, Connecticut 06520, USA
    Cancer Epidemiol Biomarkers Prev 12:1067-73. 2003
  7. pmc Telomerase expression and telomere length in breast cancer and their associations with adjuvant treatment and disease outcome
    Lingeng Lu
    Department of Epidemiology and Public Health, Yale Cancer Center, Yale University School of Medicine, New Haven, CT 06520 8034, USA
    Breast Cancer Res 13:R56. 2011

Research Grants

Collaborators

Detail Information

Publications7

  1. pmc Global burden of cancer
    Xiaomei Ma
    Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut 06520 8034, USA
    Yale J Biol Med 79:85-94. 2006
  2. pmc TGF-beta1 genotype and phenotype in breast cancer and their associations with IGFs and patient survival
    L Mu
    Department of Epidemiology and Public Health, Yale Cancer Center, Yale University School of Medicine, New Haven, CT 06520 8034, USA
    Br J Cancer 99:1357-63. 2008
    ..The study suggests a complex role of TGF-beta1 in breast cancer progression, which supports the finding of in vitro studies that TGF-beta1 has conflicting effects on tumour growth and metastasis...
  3. pmc PDCD6 is an independent predictor of progression free survival in epithelial ovarian cancer
    Dan Su
    Center for Genetic and Genomic Medicine, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China
    J Transl Med 10:31. 2012
    ..Programmed cell death 6 (PDCD6) beside its known proapoptotic functions may be a player in survival pathways in cancer. The purpose of this study is to further explore the roles of PDCD6 in epithelial ovarian cancer...
  4. ncbi request reprint Insulin-like growth factors and breast cancer risk in Chinese women
    Herbert Yu
    Department of Epidemiology and Public Health and Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut 06520 8034, USA
    Cancer Epidemiol Biomarkers Prev 11:705-12. 2002
    ..In contrast to the findings from several studies conducted in Caucasian women, we found that IGFBP-3 was positively associated with breast cancer risk in Chinese women...
  5. ncbi request reprint Plasma sex steroid hormones and breast cancer risk in Chinese women
    Herbert Yu
    Department of Epidemiology and Public Health and Yale Cancer Center, Yale University School of Medicine, New Haven, CT 06520 8034, USA
    Int J Cancer 105:92-7. 2003
    ....
  6. ncbi request reprint Joint effect of insulin-like growth factors and sex steroids on breast cancer risk
    Herbert Yu
    Yale University School of Medicine and Yale Cancer Center, New Haven, Connecticut 06520, USA
    Cancer Epidemiol Biomarkers Prev 12:1067-73. 2003
    ..In conclusion, the study suggests a possible synergy between IGF peptide hormone and sex steroid hormones, including both estrogen and androgen, in relation to breast cancer risk...
  7. pmc Telomerase expression and telomere length in breast cancer and their associations with adjuvant treatment and disease outcome
    Lingeng Lu
    Department of Epidemiology and Public Health, Yale Cancer Center, Yale University School of Medicine, New Haven, CT 06520 8034, USA
    Breast Cancer Res 13:R56. 2011
    ..This study aimed to investigate the role of telomere length and telomerase activity in breast cancer prognosis...

Research Grants2

  1. DNA Methylation, Aging, and Prostate Cancer Risk
    Herbert Yu; Fiscal Year: 2004
    ..Plasma biomarkers will be analyzed using ELISA. The findings of this study will provide insights into the possible mechanism between aging and prostate cancer and may lead to development of new markers. ..
  2. Role of Genetic and Lifestyle Interplay in Uterus Cancer
    Herbert Yu; Fiscal Year: 2007
    ..Findings of this study will provide insights into the role of mitogenic growth factors and their interaction with lifestyle factors in the etiology of endometrial cancer. ..